MedPath

Evaluating the effects of an online parenting program with peer support (PiP-Plus) for parents of adolescents (aged 12 to 17) on parent confidence and parent and adolescent wellbeing during the COVID-19 pandemic

Not Applicable
Recruiting
Conditions
COVID-19-specific parental self-efficacy
Risk and protective factors for adolescent depression and anxiety disorders that parents can potentially modify
Parental self-efficacy in parenting to reduce adolescent depression and anxiety (not COVID-19-specific)
Parent psychological distress
Adolescent depression symptoms
Adolescent anxiety symptoms
Public Health - Health promotion/education
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12621000854831
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

Parent or guardian of at least one child aged 12 to 17 years (inclusive) at baseline, who reside in Australia, have access to an internet-enabled device, and have sufficient English proficiency (self-determined) to engage in the PiP-Plus intervention.

Exclusion Criteria

No exclusion criteria specified.

We will not exclude parents who report clinically elevated symptoms of anxiety or depression in their adolescents at baseline. However, by assessing baseline symptoms, we will be able to conduct subsidiary subgroup analyses of parents of adolescents above/below clinical cut-off scores on the symptom measures, to examine the program effects on these subgroups.
The cut-off scores used to determine symptom elevation will be based on published cut-off scores, as follows:
RCADS-P depression subscale T-score of 70 or greater.
RCADS-P anxiety subscale T-score of 70 or greater.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COVID-19-specific parental self-efficacy, as measured by the total score on the COVID-19 Parental Self-Efficacy Scale (COVID-19-PSES).<br>The COVID-19-PSES was developed specifically for use in this trial.<br>The scale consists of 8 items assessing parental confidence across the parenting domains covered in the new PiP-Plus COVID-19 content.[The COVID-19-PSES will be completed at baseline and at 3-months (90 days) post-baseline completion date.<br>]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath